Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Radiopharmaceuticals. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118754876A details a three-step purification for NOTA-FAPI, ensuring high purity and stability for radiopharmaceutical manufacturing and supply chain reliability. This method controls phosphorus and TFA impurities effectively.
Patent CN115611779A details a novel nanofiltration method for radiopharmaceutical intermediates, offering significant supply chain cost reduction and high-purity scalability.
Patent CN101573330A reveals a novel stereo-selective route for trans-[18F]-FACBC precursors, offering significant cost reduction in PET tracer manufacturing and supply chain reliability.
Patent CN101481399A reveals a cost-effective route for 5'-O-DMTr-anhydrothymidine, offering significant supply chain advantages for radiopharmaceutical manufacturers.
Patent CN108299482B details a novel nucleophilic route for 18F-BPA, offering higher specific activity and safer processing for PET imaging agents.
Patent CN108299482A details a novel nucleophilic fluorination method for F-BPA, offering high specific activity and cost reduction in radiopharmaceutical manufacturing for PET imaging.
Optimized synthesis of DOTA-EB-PSMA precursor reduces HPLC steps ensuring high purity and scalable supply for prostate cancer radioligand therapy manufacturing.
Patent CN115043864A details a streamlined synthesis for F-BPA intermediates, offering reduced reaction time and improved radiochemical yield for BNCT applications.
Patent CN115010739A details a streamlined F-BPA synthesis route. This innovation offers significant cost reduction in PET tracer manufacturing and ensures high-purity supply continuity.
Patent CN114805231A reveals a high-yield, eco-friendly synthesis for p-NH2-Bn-NOTA, offering significant cost reduction and supply chain reliability for radiopharmaceutical manufacturers.